; Burzynski Clinic Presents the Results of a Phase II Study of Antineoplastons in Adult Patients with Recurrent Glioblastoma Multiforme at the Congress
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

Burzynski Clinic Presents the Results of a Phase II Study of Antineoplastons in Adult Patients with Recurrent Glioblastoma Multiforme at the Congress

VIEWS: 1 PAGES: 2

HOUSTON--(BUSINESS WIRE)--The Burzynski Clinic (BC) announced today that it has presented the results of a phase II study of antineoplastons A10 and AS2-1 (ANP) in adult patients with recurrent glioblastoma multiforme (GBM) at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology in San Francisco. GBM accounts for 60% of the primary brain tumors in adults and represents the most frequently occurring and the most malignant form of such tumors. Treatment for recurrent GBM creates

More Info
To top